Ying Wang

Dr. Ying Wang leads Codagenix’s vaccine development projects related to Flaviviruses such as Dengue and Zika. She was also the leading scientist in the recovery of COVI-VAC, Codagenix’s live attenuated vaccine against SARS-CoV-2. Prior to joining Codagenix, Dr. Wang was a postdoctoral fellow and then a Research Scientist at SUNY Stony Brook where she studied cellular signaling, developmental biology, neuronal and behavioral science. She holds a PhD in Biochemistry from the Chinese University of HK.